NewsPublic figure
What Lance Armstrong's Story Can Teach Us About Testicular Cancer
The cyclist was diagnosed with advanced testicular cancer at 25 and became a prominent advocate. Here is what that diagnosis really means, explained calmly.
A plain-language summary based on public reporting and trusted sources, linked below.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
What he described
The Guardian's 2004 account, drawing on Lance Armstrong's own memoir, sets out the sequence. "In the autumn of 1996, he noticed specks of blood appearing when he coughed. At St David's hospital in Austin, Texas, he was told that testicular cancer had spread to his lungs and his brain."
The paper reports that a two-hour operation the next day was followed by three months of intensive chemotherapy in Indianapolis. Of that period he wrote in his book: "If I wasn't in pain, I was vomiting, and if I wasn't vomiting I was thinking about what I had."
Two details there are worth pulling out. His first symptom was not in the testicle. And a cancer that had already reached the brain was still treated with the intention of curing it.
That second point is not wishful thinking. It is the standard of care.
A cancer of young men, and usually curable
For 2026 the American Cancer Society estimates about 9,810 new cases of testicular cancer and 630 deaths in the US. The National Cancer Institute (NCI) calls the disease "highly treatable, usually curable," and notes it most often develops in young and middle-aged men.
The cure figures are unusual. For seminomas across all stages combined, NCI puts the cure rate above 90%. For low-stage seminomas or nonseminomas, it says the cure rate "approaches 100%."
Risk factors are few. NCI lists an undescended testis, a family history of testis cancer particularly in a father or brother, and a personal history of testis cancer.
Feel for it
Most testicular cancers are found by the man himself. A monthly check after a warm shower, when the scrotum is relaxed, takes about a minute. Roll each testicle between thumb and fingers. Get to know what normal feels like for you.
Make an appointment within days for:
- A painless lump or hard area in a testicle, at any size
- A testicle that has changed in size, shape, or firmness
- A heavy or dragging feeling in the scrotum or lower abdomen
- New fluid collecting around a testicle
- Tenderness or growth of breast tissue, which some of these tumors cause by making hormones
- A persistent cough, coughing up blood, back pain, or a lump above the collarbone in a young man
Go to an emergency department immediately for sudden severe testicular pain. That is usually testicular torsion, a different problem, and the testicle can be lost within hours.
Do not wait for a lump to hurt. Painlessness is the norm here, and it is why men delay.
Why the surgery goes through the groin
This is a technical point with real consequences, and patients should know it.
NCI states that radical inguinal orchiectomy, removing the testicle through an incision in the groin with high tying-off of the spermatic cord, is the procedure of choice for both diagnosing and treating a suspicious testicular mass.
Cutting into the scrotum is not appropriate. NCI explains why: it risks spreading tumor into the scrotum or into the groin lymph nodes. A review of series using the scrotal approach found local recurrence in 2.9% of cases, against 0.4% with the groin approach.
If a doctor proposes a needle or scrotal biopsy of a testicular mass, ask about this directly.
Three blood tests that do a great deal
NCI states that alpha-fetoprotein, beta-human chorionic gonadotropin, and lactate dehydrogenase should all be measured before the testicle is removed. Timing matters, because levels afterward are interpreted against the starting point.
These markers do three jobs. They help classify the tumor, they set the risk group, and they track response. For nonseminomas, NCI notes that one of the strongest predictors of outcome is how far the markers fall after the testicle is removed.
Two families
There are five germ cell tumor subtypes: seminomas, embryonal carcinomas, teratomas, yolk sac tumors, and choriocarcinomas.
For treatment, everything collapses into two groups. A tumor that is 100% seminoma is a seminoma. Anything else, including mixtures containing seminoma, is managed as a nonseminoma.
There is one elegant rule worth knowing. A tumor that looks like pure seminoma but comes with a raised AFP is treated as a nonseminoma, because seminomas do not make AFP. The blood overrules the microscope.
Seminomas are more sensitive to radiation and chemotherapy. Nonseminomas may contain teratoma, which resists chemotherapy and often has to be cut out, so surgery plays a larger role there.
The risk groups, including the hardest one
For cancer that has already spread, an international classification sorts patients into three groups, based on where the disease has reached and how high the markers are.
Good-prognosis nonseminoma covers 56% to 61% of cases: five-year survival is 92% to 94%. Intermediate covers 13% to 28%: five-year survival is 80% to 83%.
Poor prognosis is defined by spread to an organ other than the lungs, or a tumor originating in the chest, or very high markers. It covers 16% to 26% of nonseminomas. Five-year progression-free survival is 41%, and five-year overall survival is 71%.
Read that last figure again. Even in the worst-prognosis group, most patients are alive at five years. NCI states plainly that "even patients with widespread metastases at presentation, including those with brain metastases, may have curable disease and should be treated with this intent."
For seminomas, 90% fall in the good-prognosis group with five-year survival of 86%, and no patients are classified as poor prognosis at all.
What treatment costs later
Cure comes with a long tail, which is why survivors need ongoing follow-up rather than discharge.
Bleomycin, one of the standard drugs, can damage the lungs. NCI notes that serious pulmonary toxicity is rare below a cumulative dose of 400 units, and that the drug is stopped at the first sign of lung trouble. Reduced lung function after treatment is common but usually reversible and usually without symptoms.
There is also a small risk to the remaining testicle. NCI reports that 0.5% to 1.0% of men have tumors in both testes at diagnosis, and another 1% to 2% develop a cancer in the other testicle later.
Fertility
This deserves plain speaking, because it is often the first question and the last one asked.
NCI notes that many men already have low sperm counts or abnormal sperm before treatment starts, and that semen analysis generally improves afterward. Most men can father children after treatment. In two large studies, roughly 70% of patients did so, often without using banked sperm.
Sperm banking before treatment is still routinely offered, and it is worth doing. It costs one appointment and removes a source of worry that can last decades.
Sources
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to Testicular cancer. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.